FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

715186005: Alirocumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3301812019 Alirocumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3301813012 Alirocumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
51051000195119 alirocumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
789951000172119 alirocumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
66181000195113 Alirocumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alirocumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Alirocumab (substance) Is a Enzyme inhibitor false Inferred relationship Some
Alirocumab (substance) Is a PCSK9 inhibitor true Inferred relationship Some
Alirocumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Proprotein convertase subtilisin/kexin type 9 inhibitor (disposition) true Inferred relationship Some
Alirocumab (substance) Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Alirocumab (substance) Is a Enzyme inhibitor protein true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Alirocumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alirocumab (substance) Inferred relationship Some 1
Product containing alirocumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alirocumab (substance) Inferred relationship Some 1
Product containing only alirocumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alirocumab (substance) Inferred relationship Some 1
Product containing alirocumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alirocumab (substance) Inferred relationship Some 1
Product containing precisely alirocumab 75 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Alirocumab (substance) Inferred relationship Some 1
Product containing precisely alirocumab 75 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alirocumab (substance) Inferred relationship Some 1
Alirocumab 150 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Alirocumab (substance) Inferred relationship Some 1
Alirocumab 150 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alirocumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start